133 related articles for article (PubMed ID: 8857179)
21. Racemate and enantiomers of ketoprofen: phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers.
Kommuru TR; Khan MA; Reddy IK
J Pharm Sci; 1998 Jul; 87(7):833-40. PubMed ID: 9649351
[TBL] [Abstract][Full Text] [Related]
22. The role of coenzyme A in the biotransformation of 2-arylpropionic acids.
Hall SD; Quan X
Chem Biol Interact; 1994 Mar; 90(3):235-51. PubMed ID: 8168172
[TBL] [Abstract][Full Text] [Related]
23. Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.
Grubb NG; Rudy DW; Brater DC; Hall SD
Br J Clin Pharmacol; 1999 Oct; 48(4):494-500. PubMed ID: 10583018
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive effects of S(+)-ketoprofen and other analgesic drugs in a rat model of pain induced by uric acid.
López-Muñoz FJ; Ventura R; Díaz I; Fernández-Guasti A; Tost D; Cabré F; Mauleón D
J Clin Pharmacol; 1998 Dec; 38(S1):11S-21S. PubMed ID: 9882077
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective serum protein binding of ketoprofen in liver diseases.
Sakai T; Maruyama T; Sako T; Ahmed S; Zuidema X; Fujiyama S; Otagiri M
Enantiomer; 1999; 4(5):477-82. PubMed ID: 10586515
[TBL] [Abstract][Full Text] [Related]
26. Photobinding of ketoprofen in vitro and ex vivo.
Moser J; Sarabia Z; Minter H; Lovell WW; van Henegouwen GM
J Photochem Photobiol B; 2000 Oct; 58(1):37-45. PubMed ID: 11195851
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
Sakai T; Maruyama T; Imamura H; Shimada H; Otagiri M
J Pharmacol Exp Ther; 1996 Aug; 278(2):786-92. PubMed ID: 8768732
[TBL] [Abstract][Full Text] [Related]
28. Inversion of (R)- to (S)-ketoprofen in eight animal species.
Aberg G; Ciofalo VB; Pendleton RG; Ray G; Weddle D
Chirality; 1995; 7(5):383-7. PubMed ID: 7495642
[TBL] [Abstract][Full Text] [Related]
29. Is the inversion from R- to S-ketoprofen concentration dependent? Investigations in rats in vivo and in vitro.
Menzel S; Sauernheimer C; Brune K; Geisslinger G
Biochem Pharmacol; 1994 Mar; 47(7):1267-70. PubMed ID: 8161357
[TBL] [Abstract][Full Text] [Related]
30. Analgesic, antiinflammatory, and antipyretic effects of S(+)-ketoprofen in vivo.
Cabré F; Fernández MF; Calvo L; Ferrer X; García ML; Mauleón D
J Clin Pharmacol; 1998 Dec; 38(S1):3S-10S. PubMed ID: 9882076
[TBL] [Abstract][Full Text] [Related]
31. Irreversible inhibition of glucose-6-phosphate dehydrogenase by the coenzyme A conjugate of ketoprofen: a key to oxidative stress induced by non-steroidal anti-inflammatory drugs?
Asensio C; Levoin N; Guillaume C; Guerquin MJ; Rouguieg K; Chrétien F; Chapleur Y; Netter P; Minn A; Lapicque F
Biochem Pharmacol; 2007 Feb; 73(3):405-16. PubMed ID: 17094951
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rats.
Yoshida H; Kohno Y; Endo H; Yamaguchi J; Fukushima K; Suwa T; Hayashi M
Biochem Pharmacol; 1997 Jan; 53(2):179-87. PubMed ID: 9037250
[TBL] [Abstract][Full Text] [Related]
33. In vivo studies on chiral inversion and amino acid conjugation of 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid in rats and dogs.
Konishi T; Nishikawa H; Kitamura S; Tatsumi K
Drug Metab Dispos; 1999 Jan; 27(1):158-60. PubMed ID: 9884325
[TBL] [Abstract][Full Text] [Related]
34. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.
Abas A; Meffin PJ
J Pharmacol Exp Ther; 1987 Feb; 240(2):637-41. PubMed ID: 3806417
[TBL] [Abstract][Full Text] [Related]
35. Stereoselective metabolism of anti-inflammatory 2-arylpropionates.
Mayer JM
Acta Pharm Nord; 1990; 2(3):197-216. PubMed ID: 2200431
[TBL] [Abstract][Full Text] [Related]
36. Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofen.
Knihinicki RD; Williams KM; Day RO
Biochem Pharmacol; 1989 Dec; 38(24):4389-95. PubMed ID: 2604741
[TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacokinetics of dexketoprofen.
Barbanoj MJ; Antonijoan RM; Gich I
Clin Pharmacokinet; 2001; 40(4):245-62. PubMed ID: 11368291
[TBL] [Abstract][Full Text] [Related]
38. In vitro distribution of ketoprofen enantiomers in articular tissues of osteoarthritic patients.
Lagrange F; Fabre T; Péhourcq F; Durandeau A; Bannwarth B
J Pharm Biomed Anal; 2001 Dec; 26(5-6):717-23. PubMed ID: 11600284
[TBL] [Abstract][Full Text] [Related]
39. Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration.
Foster RT; Jamali F
Drug Metab Dispos; 1988; 16(4):623-6. PubMed ID: 2903033
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves.
Landoni MF; Lees P
Chirality; 1995; 7(8):586-97. PubMed ID: 8593252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
